Foresight Global Investors, Inc. Novartis Ag Transaction History
Foresight Global Investors, Inc.
- $142 Billion
- Q1 2025
A detailed history of Foresight Global Investors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Foresight Global Investors, Inc. holds 187,825 shares of NVS stock, worth $21.7 Million. This represents 14.72% of its overall portfolio holdings.
Number of Shares
187,825
Previous 232,366
19.17%
Holding current value
$21.7 Million
Previous $22.6 Billion
7.4%
% of portfolio
14.72%
Previous 16.52%
Shares
7 transactions
Others Institutions Holding NVS
# of Institutions
1,524Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.37 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.2 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$996 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$817 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$783 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...